I now have all the information I need to construct a thorough, well-organized study guide. Let me compile it.
Practical 1 - Term 3, Module 5: Complete Medical Student Study Guide
This practical covers two major topics: Liver Disease Investigation (ALT assay + bilirubin measurement) and Serum Protein Electrophoresis for Gammopathy.
PART 1: INVESTIGATING LIVER DISEASE
1A. Fatty Liver (Hepatic Steatosis) - Background
Definition: Abnormal accumulation of triglycerides inside hepatocytes, causing cell swelling and liver enlargement.
Mechanism: Occurs when there is an imbalance in lipid metabolism:
- Increased delivery/production of free fatty acids to the liver (e.g., from adipose tissue lipolysis)
- Reduced beta-oxidation (breakdown) of fatty acids
- Impaired VLDL export of triglycerides from the liver
Common associations: Obesity, type 2 diabetes, dyslipidaemia (elevated LDL/non-HDL cholesterol), alcohol excess.
Clinical relevance to Mr. Nimal Perera: He had elevated total cholesterol, LDL, and non-HDL cholesterol post-MI - classic risk factors for fatty liver. The GP screened him with ALT.
1B. Alanine Transaminase (ALT) - Everything You Need to Know
What is ALT?
- ALT (formerly called SGPT - Serum Glutamic Pyruvic Transaminase) is an enzyme found predominantly in hepatocytes (cytoplasm).
- It catalyzes a transamination reaction in gluconeogenesis.
- Because it is mainly cytoplasmic and liver-specific, ALT is a sensitive and specific marker of hepatocellular injury.
The Reaction:
ALT reaction: L-Alanine + 2-oxoglutarate (α-ketoglutarate) → Pyruvate + L-Glutamate
(requires pyridoxal phosphate as coenzyme)
How ALT is Measured (Coupled Enzyme Assay):
The assay uses two sequential reactions:
- ALT reaction: Alanine + 2-oxoglutarate → Pyruvate + L-Glutamate
- Coupled reaction (LDH): Pyruvate + NADH + H⁺ → L-Lactate + NAD⁺
The rate of NADH consumption is measured photometrically (decrease in absorbance at ~340 nm). This is directly proportional to ALT activity.
Assay Type: Kinetic assay (not endpoint)
- A kinetic assay measures the rate of reaction (change in absorbance per unit time) rather than waiting for the reaction to finish.
- An endpoint assay measures absorbance at a fixed time point after the reaction is complete.
- ALT is kinetic because you continuously monitor NADH consumption over time.
Specimen Collection:
- Use a plain (red top) or SST (gold top) tube - no anticoagulant needed.
- Following centrifugation, you obtain serum.
- Serum is plasma without clotting factors. It is the standard specimen for liver function tests.
Reagent Blank:
- A reagent blank contains all reagents but no patient sample (water substituted instead).
- Why it is needed: Reagents themselves may absorb light or contain trace coloured substances. The blank corrects for this background absorbance so that only the contribution of the sample is measured, ensuring accuracy.
Calculating ALT Activity:
ALT activity is expressed in U/L (units per litre) or IU/L. The calculation uses the formula:
Activity (U/L) = (ΔA/min × Total Volume × 1000) / (ε × Light Path × Sample Volume)
where ε = molar absorption coefficient of NADH at 340 nm = 6.22 L/mmol/cm
Normal ALT reference ranges:
- Men: ~7-56 U/L
- Women: ~7-45 U/L
- Elevated ALT in the context of dyslipidaemia and obesity suggests non-alcoholic fatty liver disease (NAFLD).
AST vs ALT - Important Distinction:
- ALT - mainly cytoplasmic, liver-specific → better marker for hepatocellular damage
- AST - also found in heart, skeletal muscle, kidney, red blood cells → less specific
- AST:ALT ratio > 2:1 suggests alcoholic liver disease
- Both elevated together = hepatocellular injury
1C. Bilirubin - Everything You Need to Know
What is Bilirubin?
Bilirubin is the breakdown product of haem (from haemoglobin in senescent red blood cells). It exists in two forms in blood:
| Property | Unconjugated (Indirect) Bilirubin | Conjugated (Direct) Bilirubin |
|---|
| Solubility | Lipid-soluble, NOT water-soluble | Water-soluble |
| Albumin binding | Bound to albumin in blood | Free in plasma |
| Reaction with diazo reagent | Does NOT react directly (needs accelerator) | Reacts directly |
| Appearance in urine | NO (acholuric) | YES (choluric jaundice) |
| Blood-brain barrier | CAN cross (causes kernicterus) | Cannot cross |
Bilirubin Metabolism (simplified):
- Senescent RBCs → haemoglobin → haem → unconjugated bilirubin (in spleen/reticuloendothelial system)
- Unconjugated bilirubin transported to liver bound to albumin
- In hepatocytes: conjugated with glucuronic acid by UDP-glucuronosyltransferase → conjugated bilirubin (water-soluble)
- Conjugated bilirubin secreted into bile → intestine → urobilinogen/stercobilin → faeces
- Some urobilinogen reabsorbed → excreted in urine
Causes of Jaundice by Bilirubin Type:
Unconjugated hyperbilirubinaemia (indirect ↑):
- Haemolytic anaemias (excess RBC breakdown)
- Neonatal physiological jaundice (immature conjugating enzymes)
- Crigler-Najjar syndrome (absent/deficient UDP-glucuronosyltransferase)
- Gilbert syndrome (mild UGT1A1 mutation)
Conjugated hyperbilirubinaemia (direct ↑):
- Biliary obstruction (gallstone in common bile duct, pancreatic head cancer)
- Hepatocellular disease (hepatitis, cirrhosis) - usually mixed picture
- Dubin-Johnson syndrome, Rotor syndrome
The Van den Bergh Test (Practical Procedure):
Principle: Bilirubin reacts with diazotized sulfanilic acid (diazo reagent) to form azobilirubin (purple/blue colour). Absorbance measured at 600 nm.
Diazo reagent preparation: Sulfanilic acid + sodium nitrite + HCl → diazotized sulfanilic acid (must be prepared fresh).
Protocol summary:
| Direct (Conjugated) Bilirubin | Total Bilirubin |
|---|
| Serum | 1 ml | 1 ml |
| Water | 8.5 ml | - |
| Van den Bergh's reagent | 0.5 ml | 0.5 ml |
| Saturated ammonium sulphate | - | 0.5 ml |
| 85% Alcohol (accelerator) | - | 8 ml |
| Incubation | 30 min, room temp | 30 min, room temp |
Why alcohol is added for total bilirubin: Alcohol solubilizes unconjugated bilirubin, allowing it to react with the diazo reagent. Without it, only conjugated (water-soluble) bilirubin reacts.
After strong alkali addition: Azobilirubin turns blue - read absorbance at 600 nm.
Calculation:
Indirect bilirubin = Total bilirubin - Direct bilirubin
Important specimen handling:
- Bilirubin is photosensitive - protect from light during storage and transport.
- Keep sample refrigerated if not tested immediately.
- Avoid haemolysis (haemoglobin interferes with measurement).
Normal bilirubin values:
- Total: 0.3-1.0 mg/dL (5-17 µmol/L)
- Direct (conjugated): < 0.2 mg/dL
- Indirect: 0.2-0.8 mg/dL
- Jaundice clinically visible when total bilirubin > 2.5-3 mg/dL
Icterus in the case:
The 45-year-old man's serum sample will appear yellow-orange due to elevated bilirubin. The icterus of his sample is visible to the naked eye.
PART 2: SERUM PROTEIN ELECTROPHORESIS (SPE)
Principle of Electrophoresis
Definition: Migration of charged solutes/particles through a liquid medium under the influence of an electric field.
- Cations (positive ions) migrate toward the cathode (negative electrode)
- Anions (negative ions) migrate toward the anode (positive electrode)
- Proteins at physiological pH are mostly negatively charged → migrate toward the anode
In practice (serum protein electrophoresis):
- Support medium: agarose gel film
- Proteins separate based on their charge-to-size ratio
- Zones visualised by protein-specific staining
- Quantified by densitometry scanning → produces an electrophoretogram (electropherogram)
Factors Affecting Migration Rate:
- Net charge of the molecule (more negative = faster toward anode)
- Size and shape (larger = slower migration)
- Strength of the electric field (higher voltage = faster)
- Properties of supporting medium / buffer pH (pH fixes the charge state of proteins)
- Temperature (affects viscosity)
Key relationship: Electrophoretic mobility is directly proportional to net charge and inversely proportional to molecular size and viscosity of the medium.
Normal SPE Pattern - Protein Fractions:
| Fraction | Proteins Included | % of Total Serum Protein |
|---|
| Albumin | Albumin | ~60% |
| α₁-globulin | α₁-antitrypsin, α₁-acid glycoprotein (orosomucoid) | ~4% |
| α₂-globulin | Haptoglobin, α₂-macroglobulin, caeruloplasmin | ~8% |
| β₁-globulin | Transferrin, LDL | ~6% |
| β₂-globulin | Complement C3 | ~6% |
| γ-globulin | IgG, IgA, IgM, IgD, IgE | ~16% |
Note: The gamma fraction contains the largest portion of immunoglobulins.
Disease Patterns on Electrophoresis - What to Know:
| Disease Condition | Pattern | Explanation |
|---|
| Acute inflammation | ↑ α₁ and α₂ fractions | Acute phase proteins (CRP, haptoglobin, fibrinogen, α₁-antitrypsin) are produced by the liver in response to inflammation/cytokines (IL-6). Albumin may be slightly ↓. |
| Chronic inflammation | ↑ α₂ + ↑ γ-globulin (broad/polyclonal) | Ongoing acute phase response + long-term immune stimulation producing polyclonal immunoglobulins. |
| Chronic liver cell disease (cirrhosis) | ↓ Albumin + broad ↑ γ (β-γ bridging) | Liver fails to synthesise albumin. Immunoglobulins (especially IgA in alcoholic cirrhosis) increase and merge with β fraction producing characteristic β-γ bridge. |
| Paraproteinaemia / Monoclonal Gammopathy (e.g., Multiple Myeloma, MGUS) | Narrow, tall, discrete "M-spike" in β or γ region | A single malignant plasma cell clone produces one identical immunoglobulin type (monoclonal protein = paraprotein). Appears as a sharp, narrow spike in contrast to normal broad γ band. |
| Hypogammaglobulinaemia | ↓ or absent γ fraction | Reduced immunoglobulin production (e.g., X-linked agammaglobulinaemia, common variable immunodeficiency, immunosuppression, nephrotic syndrome with protein loss). |
Gammopathy - Key Concepts:
Gammopathy = increase in immunoglobulins.
- Polyclonal gammopathy: Many plasma cell clones each producing different Ig → broad diffuse rise in γ region. Seen in infections, autoimmune disease, chronic liver disease.
- Monoclonal gammopathy: Single clone → sharp M-spike. Seen in:
- MGUS (Monoclonal Gammopathy of Undetermined Significance) - benign
- Multiple myeloma (malignant plasma cell tumour)
- Waldenström macroglobulinaemia (IgM M-spike)
- Lymphoma, amyloidosis
Immunofixation electrophoresis (IFE) has higher sensitivity than SPE for identifying the heavy and light chain type of a paraprotein.
KEY EXAM POINTS - Quick Reference
- ALT is a kinetic assay - measures rate of NADH decrease at 340 nm
- ALT > 56 U/L = hepatocellular injury; AST:ALT > 2 suggests alcohol
- Direct bilirubin = conjugated (water-soluble, reacts without accelerator)
- Indirect bilirubin = total - direct (needs alcohol to react with diazo)
- Van den Bergh's test reads at 600 nm after alkali addition (blue azobilirubin)
- Bilirubin samples must be protected from light (photodegradation)
- Albumin is ~60% of serum protein - reduced in chronic liver disease and malnutrition
- M-spike = monoclonal gammopathy → must investigate for myeloma
- β-γ bridging on SPE = classic pattern of alcoholic/chronic liver cirrhosis
- Reagent blank corrects for background absorbance from reagents themselves
Sources: Basic Medical Biochemistry (Lieberman & Peet, 6e); Harper's Illustrated Biochemistry (32e); Harrison's Principles of Internal Medicine (22e); Goldman-Cecil Medicine; Schwartz's Principles of Surgery (11e)